BNTC - Benitec Biopharma Inc
IEX Last Trade
9.02
-0.030 -0.333%
Share volume: 12,373
Last Updated: Fri 30 Aug 2024 08:50:40 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$9.05
-0.03
-0.33%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-05-16 | 2022-09-02 | 2022-11-10 | 2023-02-13 | 2023-05-15 | 2023-09-21 | 2023-11-13 | 2024-02-13 | |
| Total revenue | 48.000 K | 0.000 | 0.000 | 14.000 K | 54.000 K | 7.000 K | 106.000 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 48.000 K | 0.000 | 0.000 | 14.000 K | 54.000 K | 7.000 K | 106.000 K | 0.000 | |
| -100.00% | nan% | inf% | 285.71% | -87.04% | 1,414.29% | -100.00% | |||
| Operating expenses | 3.508 M | 4.728 M | 4.580 M | 5.624 M | 4.395 M | 4.557 M | 5.980 M | 6.926 M | |
| Selling general and admin | 1.337 M | 1.553 M | 1.920 M | 1.863 M | 1.228 M | 1.371 M | 1.551 M | 1.824 M | |
| Research and development | 2.171 M | 3.175 M | 2.660 M | 3.761 M | 3.167 M | 3.186 M | 4.429 M | 5.102 M | |
| Total expenses | 3.508 M | 4.737 M | 4.580 M | 5.624 M | 4.395 M | 4.557 M | 5.980 M | 6.927 M | |
| 35.03% | -3.31% | 22.79% | -21.85% | 3.69% | 31.23% | 15.84% | |||
| Operating income | -3.460 M | -4.737 M | -4.580 M | -5.610 M | -4.341 M | -4.550 M | -5.874 M | -6.927 M | |
| Ebit | -3.460 M | -4.737 M | -4.580 M | -5.610 M | -4.341 M | -4.550 M | -5.874 M | -6.927 M | |
| Pretax income | -3.275 M | -5.067 M | -5.093 M | -5.411 M | -4.397 M | -4.661 M | -5.954 M | -6.798 M | |
| 54.72% | 0.51% | 6.24% | -18.74% | 6.00% | 27.74% | 14.18% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -3.275 M | -5.067 M | -5.093 M | -5.411 M | -4.397 M | -4.661 M | -5.954 M | -6.798 M | |
| -54.72% | -0.51% | -6.24% | 18.74% | -6.00% | -27.74% | -14.18% | |||
| Net income | -3.275 M | -5.067 M | -5.093 M | -5.411 M | -4.397 M | -4.661 M | -5.954 M | -6.798 M | |
| -54.72% | -0.51% | -6.24% | 18.74% | -6.00% | -27.74% | -14.18% |